Adults aged 18-21 with Down syndrome who have sleep apnea after a tonsillectomy are needed for a research study. The purpose of this research study is to find out if a surgically implanted nerve stimulator called The Inspire® System is safe and effective in treating sleep apnea. Study involves at least 9 visits over 1 year.
Obstructive sleep apnea is a disorder in which the airway is blocked during sleep, causing difficulty breathing. People with Down syndrome are more likely to have sleep apnea, and may have their tonsils surgically removed (called a tonsillectomy) in an effort to treat the disorder. Unfortunately, tonsillectomy is not always effective and many people continue to experience symptoms of sleep apnea. Other treatments are available, but may be difficult to use.
The purpose of this research study is to find out if an implanted nerve stimulation system called The Inspire® System is a safe and effective treatment for young adults with Down syndrome who have moderate to severe obstructive sleep apnea. By stimulating a nerve under the chin (called the hypoglossal nerve) with mild electrical stimulation, the tongue is lifted up from the back of the throat, which may help reopen the airway. While the hypoglossal nerve stimulator has been used in adults to treat obstructive sleep apnea, it has not yet been tested in adolescents, young adults, or in people with Down syndrome.
COULD THIS STUDY BE RIGHT FOR YOU?
• Ages 18-21
• Have Down syndrome
• Had a prior tonsillectomy
• Diagnosed with moderate to severe obstructive sleep apnea (OSA)
• Able to communicate pain or discomfort
WHAT PARTICIPANTS CAN EXPECT
Participation involves at least 9 visits over 12 months. Some visits will take 1-2 hours, and others will require participants to spend the night for a sleep study. After an initial screening visit, participants will meet with the surgeon, have an overnight sleep study, and have a sleep endoscopy.
Following these visits, participants will have surgery to place the implanted hypoglossal nerve stimulation system. After the device is turned on, participants will have multiple follow up visits and complete questionnaires over the course of 11 months.
IRB:PRO16050436B - A pilot study to evaluate safety and efficacy of the hypoglossal nerve stimulator in the treatment of adolescents with Down syndrome with obstructive sleep apnea
DURATION: 1 year
VISITS: 9 visits
UPMC Children’s Hospital of Pittsburgh